These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 26043844

  • 1. Comparative analysis of Rb1, P16 and ER as diagnostic, prognostic and potential targets for therapeutic agents in ovarian epithelial tumors: an immunohistochemical study of 130 ovarian carcinomas.
    Ferguson DC, Long DJ, Smith MC, Craig-Owens LD, Means J, Fadare O, Desouki MM.
    J Ovarian Res; 2015 Jun 05; 8():34. PubMed ID: 26043844
    [Abstract] [Full Text] [Related]

  • 2. Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.
    Milea A, George SH, Matevski D, Jiang H, Madunic M, Berman HK, Gauthier ML, Gallie B, Shaw PA.
    Mod Pathol; 2014 Jul 05; 27(7):991-1001. PubMed ID: 24336157
    [Abstract] [Full Text] [Related]

  • 3. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
    Lee YH, Heo JH, Kim TH, Kang H, Kim G, Kim J, Cho SH, An HJ.
    Int J Gynecol Pathol; 2011 May 05; 30(3):205-17. PubMed ID: 21464733
    [Abstract] [Full Text] [Related]

  • 4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 5. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL, Hsu CS, Liu WM, Lee YC, Lee YC, Chen CL.
    Int J Clin Exp Pathol; 2015 Oct 25; 8(5):5642-9. PubMed ID: 26191276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Loss of expression of the p16 tumor suppressor gene is more frequent in advanced ovarian cancers lacking p53 mutations.
    Havrilesky LJ, Alvarez AA, Whitaker RS, Marks JR, Berchuck A.
    Gynecol Oncol; 2001 Dec 25; 83(3):491-500. PubMed ID: 11733961
    [Abstract] [Full Text] [Related]

  • 9. A comprehensive immunohistochemical analysis of 26 markers in 250 cases of serous ovarian tumors.
    Němejcová K, Šafanda A, Bártů MK, Michálková R, Drozenová J, Fabian P, Hausnerová J, Laco J, Matěj R, Méhes G, Škapa P, Stružinská I, Dundr P.
    Diagn Pathol; 2023 Feb 28; 18(1):32. PubMed ID: 36855066
    [Abstract] [Full Text] [Related]

  • 10. Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.
    Qiu C, Wang Y, Wang X, Zhang Q, Li Y, Xu Y, Jin C, Bu H, Zheng W, Yang X, Lu N, Kong B.
    Int J Oncol; 2018 Jun 28; 52(6):2041-2050. PubMed ID: 29620196
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.
    Llaurado Fernandez M, Dawson A, Kim H, Lam N, Russell H, Bruce M, Bittner M, Hoenisch J, Scott SA, Talhouk A, Chiu D, Provencher D, Nourmoussavi M, DiMattia G, Lee CH, Gilks CB, Köbel M, Carey MS.
    Gynecol Oncol; 2020 Apr 28; 157(1):12-20. PubMed ID: 31954537
    [Abstract] [Full Text] [Related]

  • 17. Functional estrogen receptor signaling pathway activity in high-grade serous ovarian carcinoma as compared to estrogen receptor protein expression by immunohistochemistry.
    van der Ploeg P, van Lieshout LAM, van de Stolpe A, Bosch SL, Lentjes-Beer MHFM, Bekkers RLM, Piek JMJ.
    Cell Oncol (Dordr); 2021 Aug 28; 44(4):951-957. PubMed ID: 33723801
    [Abstract] [Full Text] [Related]

  • 18. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Ramón Y Cajal T, Hernández-Agudo E, Heredia Soto V, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ.
    J Gynecol Oncol; 2016 Jan 28; 27(1):e7. PubMed ID: 26463438
    [Abstract] [Full Text] [Related]

  • 19. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas.
    Ghazizadeh M, Jin E, Shimizu H, Fujiwara M, Arai S, Ohaki Y, Takemura T, Kawanami O.
    Respiration; 2005 Jan 28; 72(1):68-73. PubMed ID: 15753637
    [Abstract] [Full Text] [Related]

  • 20. Loss of p16INK4A expression in low-grade ovarian serous carcinomas.
    Schlosshauer PW, Deligdisch L, Penault-Llorca F, Fatemi D, Qiao R, Yao S, Pearl M, Yang Z, Sheng T, Dong J.
    Int J Gynecol Pathol; 2011 Jan 28; 30(1):22-9. PubMed ID: 21131838
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.